Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the effects of fondaparinux on biochemical parameters and clinical events according to different duration of treatment in heart failure patients (III-IV NYHA). Primary end-point: circulating D-dimer plasma levels 2 months after enrolment
Critère d'inclusion
- heart failure patients (III-IV NYHA)